Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Varenicline treatment for smokers with schizophrenia: a case series.

Evins AE, Goff DC.

J Clin Psychiatry. 2008 Jun;69(6):1016. No abstract available.

2.

Comment: Oral varenicline for smoking cessation.

Gonzales D, Rennard SI, Jorenby DE, Reeves KR.

Ann Pharmacother. 2007 Apr;41(4):720-1. Epub 2007 Mar 20. No abstract available.

PMID:
17374627
3.

Varenicline in smoking cessation.

Tonstad S, Rollema H.

Expert Rev Respir Med. 2010 Jun;4(3):291-9. doi: 10.1586/ers.10.27. Review.

PMID:
20524911
4.

Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.

Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR.

Arch Intern Med. 2011 Apr 25;171(8):770-7. doi: 10.1001/archinternmed.2011.138.

PMID:
21518946
5.

Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.

Dutra SJ, Stoeckel LE, Carlini SV, Pizzagalli DA, Evins AE.

Psychopharmacology (Berl). 2012 Jan;219(1):25-34. doi: 10.1007/s00213-011-2373-6. Epub 2011 Jun 22.

6.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
7.

New non-nicotine drug to help smoking cessation efforts.

O'Dowd A.

Nurs Times. 2007 Jun 12-18;103(24):23-4. No abstract available.

PMID:
17598689
8.

The place of varenicline in smoking cessation treatment.

Aveyard P.

Thorax. 2008 Aug;63(8):666-8. doi: 10.1136/thx.2008.096081. No abstract available.

PMID:
18663065
9.

Efficacy of varenicline for smoking cessation.

Dervaux A, Kanit M, Laqueille X.

JAMA. 2006 Dec 6;296(21):2555; author reply 2555-6. No abstract available.

PMID:
17148718
10.

Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.

Weiner E, Buchholz A, Coffay A, Liu F, McMahon RP, Buchanan RW, Kelly DL.

Schizophr Res. 2011 Jun;129(1):94-5. doi: 10.1016/j.schres.2011.02.003. Epub 2011 Mar 4. No abstract available.

11.

Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!

[No authors listed]

Prescrire Int. 2014 Sep;23(152):208. No abstract available.

PMID:
25325119
12.

New kid on the block: Chantix for smoking cessation.

Rankin KV.

Tex Dent J. 2008 May;125(5):432-3. No abstract available.

PMID:
18561798
13.

Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.

Meszaros ZS, Abdul-Malak Y, Dimmock JA, Wang D, Ajagbe TO, Batki SL.

J Clin Psychopharmacol. 2013 Apr;33(2):243-7. doi: 10.1097/JCP.0b013e3182870551.

PMID:
23422399
14.

Varenicline efficacy and tolerability in a subject with schizophrenia.

Fatemi SH.

Schizophr Res. 2008 Aug;103(1-3):328-9. doi: 10.1016/j.schres.2008.05.002. Epub 2008 Jun 24. No abstract available.

PMID:
18572388
15.

Varenicline (Chantix) for tobacco dependence.

[No authors listed]

Med Lett Drugs Ther. 2006 Aug 14-28;48(1241-1242):66-8. No abstract available.

PMID:
16977281
16.

Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.

Zeng F, Chen CI, Mastey V, Zou KH, Harnett J, Patel BV.

Am J Manag Care. 2010 Sep;16(9):667-74.

17.

[Varenicline--a new drug for smoking cessation].

Tønnesen P.

Ugeskr Laeger. 2007 Nov 19;169(47):4051-2. Danish.

PMID:
18078657
19.

Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders.

Castle D, Baker AL, Richmond R, Filia SL, Harris D, Pirola-Merlo AJ.

Ann Clin Psychiatry. 2012 Nov;24(4):285-91.

PMID:
23145385
20.

Letter by Smolderen and Pelle regarding article, "Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial".

Smolderen KG, Pelle AJ.

Circulation. 2010 Aug 31;122(9):e445; author reply e446. doi: 10.1161/CIRCULATIONAHA.110.942086. No abstract available.

Supplemental Content

Support Center